BOSTON - Vertex Pharmaceuticals (NASDAQ: VRTX) shares tumbled 8.7% after the company announced its experimental pain drug VX-993 failed to meet the primary endpoint in a Phase 2 clinical trial, ...

Carronade Capital has been advocating for the separation of Viasat’s Defense and Advanced Technologies segment, arguing it could be one of the most attractive pure-play defense technology platforms in ...

Investing.com -- India’s Nifty index could touch fresh highs in the coming months, says Morgan Stanley, saying that a ...

Investing.com -- Israeli Prime Minister Benjamin Netanyahu is considering expanding military operations in Gaza to seize the entire enclave, according to an official from his office cited by Israel’s ...

Investing.com -- U.S. President Donald Trump announced Monday he plans to "substantially" raise tariffs on India, citing the country’s purchases and sales of Russian oil amid the ongoing conflict in ...

Investing.com -- Stifel downgraded Baxter International (NYSE: BAX) to Hold from Buy and slashed its price target to $25 from $36, citing a weaker-than-expected second quarter and a longer timeline ...

Investing.com -- The United States will implement a pilot program requiring bonds of up to $15,000 for certain tourist and business visa applicants, according to a U.S. government notice released ...

Investing.com -- Equillium Inc (NASDAQ: EQ) stock tumbled 12.4% after the biotechnology company announced plans to integrate cryptocurrency into its treasury reserve strategy, a significant deviation ...

Switzerland says it continues to negotiate with U.S. Investing.com -- The Swiss government announced Monday it will continue negotiations with the United States regarding tariffs after experts warned ...

Barclays (LON: BARC) has upgraded Air France-KLM (EPA: AIRF), Lufthansa (ETR: LHAG) and International Airlines Group (VIE: ...

Given that the labor market and economy are truly showing signs of weakening and tariffs are not overly impacting inflation, it seems Trump has a case. That said, it may be a few more months before ...

Evercore lays out two scenarios. In a benign case, only a few changes occur, leading to a Fed led by a Trump-appointed chair but operating within existing norms. In this version, monetary policy would ...